Back
TScan Therapeutics Vs. V2X Industry Stock Comparison
Sell
41
TCRX
TScan Therapeutics
Last Price:
$1.82
Seasonality Move:
-6.1%
Buy
57
VVX
V2X
Last Price:
$48.55
Seasonality Move:
-5.11%
Sell
41
TScan Therapeutics (TCRX)
is a Sell
Is TScan Therapeutics a Buy, Sell or Hold?
-
The current TScan Therapeutics [TCRX] share price is $1.84. The Score for TCRX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
TCRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TCRX Stock Price Chart
What is TScan Therapeutics's stock price today?
-
The TScan Therapeutics share price today is $1.84Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TCRX is experiencing slight buying pressure.
VVX Stock Price Chart
TCRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 64.23 | Buy |
Chaikin Money Flow: | 89200 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.45 - 1.73) | Buy |
Bollinger Bands (100): | (1.31 - 1.83) | Buy |
VVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.31 | Buy |
Relative Strength Index (14 RSI): | 65.66 | Buy |
Chaikin Money Flow: | -4296 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.61 - 48.79) | Buy |
Bollinger Bands (100): | (45.35 - 50.13) | Buy |
TCRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.59 | Buy |
20-day SMA: | 1.55 | Buy |
50-day SMA: | 1.5 | Buy |
200-day SMA: | 2.78 | Sell |
8-day EMA: | 0.96 | Buy |
20-day EMA: | 0.47 | Buy |
50-day EMA: | 0.2 | Buy |
200-day EMA: | 0.05 | Buy |
VVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.3 | Buy |
20-day SMA: | 47.2 | Buy |
50-day SMA: | 47.52 | Buy |
200-day SMA: | 52.1 | Sell |
8-day EMA: | 26.21 | Buy |
20-day EMA: | 12.83 | Buy |
50-day EMA: | 5.59 | Buy |
200-day EMA: | 1.46 | Buy |
TScan Therapeutics Earnings Growth & TCRX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.11 per share, and an increase next year of $0.07 per share.
V2X Earnings Growth & VVX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.60 per share, and an increase next year of $0.72 per share.
TScan Therapeutics Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
V2X Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |